A silo mentality is an issue for any organisation, but it is particularly problematic for the pharmaceutical industry.
Drug development is a multidisciplinary endeavour that relies on the cumulative efforts of highly skilled teams in order to be successful. Yet these teams cannot work in isolation. Few development challenges reside within their own ‘bubble’; without careful planning and good communication, the solutions adopted to overcome one obstacle can have a significant knock-on effect elsewhere in the development pipeline.
You just need to REGISTER - its FREE - to read the rest of this article straight away.